Nanotechnology platform enables immune conversion of cancer cells, sensitizing them to immunotherapy
| Date | 10th, Nov 2022 |
|---|---|
| Source | Nanowerk - Nanotechnology Websites |
DESCRIPTION
Preclinical study uses nanoparticles to attach immune-activating molecule to tumors.